{"id":"https://openalex.org/W2016261495","doi":"https://doi.org/10.1517/14656561003677382","title":"Castrate-resistant prostate cancer: therapeutic strategies","display_name":"Castrate-resistant prostate cancer: therapeutic strategies","publication_year":2010,"publication_date":"2010-03-22","ids":{"openalex":"https://openalex.org/W2016261495","doi":"https://doi.org/10.1517/14656561003677382","mag":"2016261495","pmid":"https://pubmed.ncbi.nlm.nih.gov/20307219"},"language":"en","primary_location":{"id":"doi:10.1517/14656561003677382","doi":"https://doi.org/10.1517/14656561003677382","is_oa":false,"landing_page_url":"https://doi.org/10.1517/14656561003677382","pdf_url":null,"source":{"id":"https://openalex.org/S52020611","display_name":"Expert Opinion on Pharmacotherapy","issn_l":"1465-6566","issn":["1465-6566","1744-7666"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Pharmacotherapy","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066372195","display_name":"Andrea Lynne Harzstark","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrea L Harzstark","raw_affiliation_strings":["University of California, Urologic Oncology, San Francisco, CA 94143, USA.Andrea.harzstark@ucsf.edu","+1 415 353 7093","University of California, 1600 Divisadero St., Urologic Oncology, Box 1711, San Francisco, CA 94143, USA +1 415 353 9278"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, Urologic Oncology, San Francisco, CA 94143, USA.Andrea.harzstark@ucsf.edu","institution_ids":["https://openalex.org/I180670191"]},{"raw_affiliation_string":"+1 415 353 7093","institution_ids":[]},{"raw_affiliation_string":"University of California, 1600 Divisadero St., Urologic Oncology, Box 1711, San Francisco, CA 94143, USA +1 415 353 9278","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5007578304","display_name":"Eric Jay Small","orcid":"https://orcid.org/0000-0003-3191-6268","observed_orcids":["https://orcid.org/0000-0003-3191-6268"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric J Small","raw_affiliation_strings":["University of California, 1600 Divisadero St., Urologic Oncology, Box 1711, San Francisco, CA 94143, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California, 1600 Divisadero St., Urologic Oncology, Box 1711, San Francisco, CA 94143, USA","institution_ids":["https://openalex.org/I180670191"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I180670191"],"apc_list":null,"apc_paid":null,"fwci":0.5092,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.40643144,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"11","issue":"6","first_page":"937","last_page":"945"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/castration-resistant-prostate-cancer","display_name":"castration-resistant prostate cancer","score":0.9940000176429749},{"id":"https://openalex.org/keywords/chemotherapy-regimens","display_name":"chemotherapy regimens","score":0.6840000152587891},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.9639999866485596},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.9789999723434448},{"id":"https://openalex.org/keywords/endothelin-a-receptor-antagonist","display_name":"endothelin A receptor antagonist","score":0.996999979019165},{"id":"https://openalex.org/keywords/novel-therapeutic-agents","display_name":"novel therapeutic agents","score":0.5849999785423279},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.39500001072883606}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9409874677658081},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.7665277123451233},{"id":"https://openalex.org/C2779476363","wikidata":"https://www.wikidata.org/wiki/Q14864935","display_name":"Clusterin","level":3,"score":0.6698271036148071},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5536671876907349},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4878218472003937},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.48526331782341003},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4734969735145569},{"id":"https://openalex.org/C2776235491","wikidata":"https://www.wikidata.org/wiki/Q9625","display_name":"Prostate","level":3,"score":0.4233478903770447},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.412896990776062},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.41075146198272705},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.06455141305923462},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000074324","descriptor_name":"Ipilimumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000726","descriptor_name":"Androgen Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D019496","descriptor_name":"Cancer Vaccines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1517/14656561003677382","doi":"https://doi.org/10.1517/14656561003677382","is_oa":false,"landing_page_url":"https://doi.org/10.1517/14656561003677382","pdf_url":null,"source":{"id":"https://openalex.org/S52020611","display_name":"Expert Opinion on Pharmacotherapy","issn_l":"1465-6566","issn":["1465-6566","1744-7666"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Pharmacotherapy","raw_type":"journal-article"},{"id":"pmid:20307219","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20307219","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on pharmacotherapy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":41,"referenced_works":["https://openalex.org/W1529350477","https://openalex.org/W1894792990","https://openalex.org/W1973335417","https://openalex.org/W1974425256","https://openalex.org/W1998577461","https://openalex.org/W2007793269","https://openalex.org/W2023659903","https://openalex.org/W2036245537","https://openalex.org/W2038396278","https://openalex.org/W2049163935","https://openalex.org/W2049820493","https://openalex.org/W2049900215","https://openalex.org/W2069549911","https://openalex.org/W2080439368","https://openalex.org/W2092991204","https://openalex.org/W2099549837","https://openalex.org/W2100128029","https://openalex.org/W2103090668","https://openalex.org/W2114662812","https://openalex.org/W2119504728","https://openalex.org/W2120292596","https://openalex.org/W2126504358","https://openalex.org/W2129660626","https://openalex.org/W2130227816","https://openalex.org/W2130803372","https://openalex.org/W2135172646","https://openalex.org/W2143289308","https://openalex.org/W2149752186","https://openalex.org/W2151930316","https://openalex.org/W2155995527","https://openalex.org/W2158891951","https://openalex.org/W2159545091","https://openalex.org/W2164828052","https://openalex.org/W2170887853","https://openalex.org/W2232361377","https://openalex.org/W2243567906","https://openalex.org/W2247866879","https://openalex.org/W2278807231","https://openalex.org/W2337805480","https://openalex.org/W2423112668","https://openalex.org/W2985905496"],"related_works":["https://openalex.org/W2148445666","https://openalex.org/W2103758696","https://openalex.org/W2021957789","https://openalex.org/W2504141425","https://openalex.org/W2051034135","https://openalex.org/W1498647927","https://openalex.org/W2370460447","https://openalex.org/W1989850113","https://openalex.org/W2087310441","https://openalex.org/W1981713494"],"abstract_inverted_index":{"IMPORTANCE":[0],"OF":[1],"THE":[2,49],"FIELD:":[3],"Castrate-resistant":[4],"prostate":[5,82],"cancer":[6],"continues":[7],"to":[8],"be":[9],"inadequately":[10],"addressed":[11],"by":[12],"currently":[13,77],"available":[14],"therapies.":[15],"AREAS":[16],"COVERED":[17],"IN":[18],"THIS":[19],"REVIEW:":[20],"This":[21],"review":[22],"will":[23,55],"discuss":[24],"recent":[25],"developments,":[26],"including":[27],"new":[28,38],"chemotherapies":[29],"and":[30,36,45],"chemotherapy":[31],"regimens,":[32],"antiangiogenic":[33],"therapy,":[34],"immunotherapy,":[35],"other":[37],"agents,":[39],"such":[40],"as":[41],"endothelin-A":[42],"receptor":[43],"antagonists":[44],"clusterin":[46],"inhibitors.":[47],"WHAT":[48],"READER":[50],"WILL":[51],"GAIN:":[52],"The":[53],"reader":[54],"gain":[56],"an":[57],"understanding":[58],"of":[59],"the":[60],"therapies":[61],"in":[62],"development":[63],"for":[64,80],"castration-resistant":[65],"disease.":[66],"TAKE":[67],"HOME":[68],"MESSAGE:":[69],"Therapies":[70],"focused":[71],"on":[72],"multiple":[73],"different":[74],"targets":[75],"are":[76],"being":[78],"studied":[79],"castrate-resistant":[81],"cancer.":[83]},"counts_by_year":[{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}